23636/34351US=64 / Câncer
Narayanan S, Tong FC. Percutaneous vertebroplasty and balloon kyphoplasty for the treatment of acute painful pathologic fracture. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 469-89. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

VERTEBROPLASTIA PERCUTANEA; CIFOPLASTIA; TRATAMENTO DE FRATURA DOLOROSA


23637/34351US=64 / Câncer
Durie BGM. The role of anatomic and functional imaging in myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 491-8. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

PAPEL DA IMAGEM ANATOMICA EM MIELOMA; PAPEL DA IMAGEM FUNCIONAL EM MIELOMA


23638/34351US=64 / Câncer
Ailawadhi S, Chanan-Khan A. Management of multiple myeloma patients with renal dysfunction. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 499-516. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

MIELOMA MULTIPLO COM DISFUNCAO RENAL. TRATAMENTO


23639/34351US=64 / Câncer
Simpson L, Gertz M. Waldenstrom's macroglobulinemia. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 519-50. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

MACROGLOBULINEMIA DE WALDENSTROM; WM


23640/34351US=64 / Câncer
Sanchorawala V. AL (immunoglobulin light-chain amyloidosis). In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 551-69. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

AL; AMILOIDOSE IMUNOGLOBULINA


23641/34351US=64 / Câncer
Dispenzieri A. POEMS syndrome and other atypical plasma cell disorders. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 571-623. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

SINDROME POEMS; DOENCAS DE CELULAS ATIPICAS DE PLASMA


23642/34351US=64 / Câncer
Kyle RA, Rajkumar SV. Monoclonal gammopathy of undetermined significance. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 625-49. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

GAMOPATIA MONOCLONAL


23643/34351US=65 / Biol/Mol
Puente XS, Ordóñez GR, López-Otín C. Protease genomics and the cancer degradome. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 3-15. ISBN 978-0-387-69056-8.

GENOMICA DE PROTEASE; CANCER DEGRADOME; DEGRADOME HUMANO; PESQUISA; REPERTORIO INIBIDOR DA PROTEASE; DEGRADOMES MAMIFEROS


23644/34351US=65 / Biol/Mol
Kappelhoff R, Wilson CH, Overall CM. The CLIP-CHIP: a focused oligonucleotide microarray platform for transcriptome analysis of the complete human and murine cancer degradomes. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 17-35. ISBN 978-0-387-69056-8.

CLIP CHIP; MICROARRAY; OLIGONUCLEOTIDEO; ANALISE DO TRANSCRIPTOMA; DEGRADOMES CANCEROSAS HUMANAS; MURINAS; PROTEASES; PROTEASE WEB; MICROARRAYS TRANSCRIPTOMICAS; TECNOLOGIA MICROARRAYS


23645/34351US=65 / Biol/Mol
Schwartz DR, Moin K, Weber E, Sloane BF. The Hu/Mu ProtIn Chip: a custom dual-species oligonucleotide microarray for profiling degradome gene expression in tumors and their microenvironment. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 37-47. ISBN 978-0-387-69056-8.

HU/MU CHIP PROTIN; MICROARRAY; OLIGONUCLEOTIDEO PERSONALIZADO; EXPRESSAO DO GENE; DEGRADOME


23646/34351US=65 / Biol/Mol
Pennington CJ, Nuttall RK, Sampieri-Ramirez C, Wallard M, Pilgrim S, Edwards DR. Quantitative real-time PCR analysis of degradome gene expression. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 49-65. ISBN 978-0-387-69056-8.

QUANTITATIVO EM TEMPO REAL; ANALISE DE PCR; EXPRESSAO DO GENE DEGRADOME


23647/34351US=65 / Biol/Mol
Enoksson M, Zhu W, Salvesen GS. Identification of protease substrates by mass spectrometry approaches-1. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 67-82. ISBN 978-0-387-69056-8.

IDENTIFICACAO DE SUBSTRATOS DA PROTEASE; ESPECTROMETRIA DE MASSA; SUBSTRATOS NATURAIS; METODOS PROTEOMICOS; PROTEINA; PEPTIDEO; ROTULAGEM ICAT; REAGENTES AMINO-REATIVOS; ROTULAGEM ITRAQ; PEPTIDEOS TRIPTICOS; ROTULO ISENTO DE ANALISE


23648/34351US=65 / Biol/Mol
Prudova A, Keller U, Overall CM. Indentification of protease substrates by mass spectrometry approaches-2. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 83-100. ISBN 978-0-387-69056-8.

SUBSTRATOS DA PROTEAS; ESPECTROMETRIA DE MASSA; ELECTROFORESE BIDIMENSIONAL EM GEL; PROTEOMICA SHOTGUN; PROTEOMICA QUANTITATIVA; ICATS; ITRAQ


23649/34351US=65 / Biol/Mol
Dive V, Paulick MG, McIntyre JO, Matrisian LM, Bogyo M. Activity-based imaging and biochemical profiling tools for analysis of the cancer degradome. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 101-35. ISBN 978-0-387-69056-8.

IMAGEM; FERRAMENTAS DE PERFIL BIOQUIMICOS; ANALISE DO DEGRADOME CANCER; ATIVIDADE DA PROTEASE; SUBSTRATO A BASE DE AGENTES DE IMAGEM; PLAS DE PROTEASES; CISTEINA; SERINA; SONDAS; ATIVIDADE DE METALOPROTEASE


23650/34351US=65 / Biol/Mol
Moin K, Sameni M, Jedeszko C, Li Q, Olive MB, Mattingly RR, Sloane BF. Images of cleavage: tumor proteases in action. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 137-54. ISBN 978-0-387-69056-8.

IMAGENS DE CLIVAGEM; PROTEASES TUMORAIS; ATIVIDADE DE PROTEASES; IMAGEM INDIVIDUAIS; CLASSES DE PROTEASES; SUBSTRATOS SINTETICOS; IMAGIOLOGIA; ATIVIDADE PROTEOLITICA DE CELULAS VIVAS; IMAGEM DA ATIVIDADE PROTEOLITICA; INTERACOES DE CELULAS VIVAS; SISTEMAS MODELO; MICROAMBIENTE TUMORAL; IMAGIOLOGIA DE MODULACAO DA PROTEOLISE; ANALISE DA IMAGEM; METODOS DE PROCESSAMENTO DOS DADOS; QUANTIFICACAO DE PROTEOLISE


23651/34351US=65 / Biol/Mol
Affara NI, Coussens LM. Proteolytic pathways: intersecting cascades in cancer development. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 157-82. ISBN 978-0-387-69056-8.

VIAS PROTEOLITICAS; INTERSECCAO NO DESENVOLVIMENTO DO CANCER; PROTEASES; ATIVACAO METALOPROTEASE; FUNCAO METALOPROTEASE; REGULACAO DE SERINO PROTEASES; ATIVADORES DO PLASMINOGENIO; PROTEASES DE SERINA MASTOCITOS; NEUTROFILOS DERIVADOS DE SERINA PROTEASES; CATEPSINA PROTEASES DE CISTEINA


23652/34351US=65 / Biol/Mol
Almholt K, Juncker-Jensen A, Green KA, Solberg H, Lund LR, Romer J. The plasminogen activation system in tissue remodeling and cancer invasion. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 203-21. ISBN 978-0-387-69056-8.

SISTEMA DE ATIVACAO DO PLASMINOGENIO; REMODELACAO DO TECIDO; INVASAO DE CANCER; PROTEOLISE EXTRACELULAR; CICATRIZACAO DE FERIDAS; IMPLANTACAO DO EMBRIAO; INVOLUCAO DA GLANDULA MAMARIA POS-LACTATIONAL; CANCER DE MAMA METASTATICO; MMTV-PYMT


23653/34351US=65 / Biol/Mol
D'Alessio S, Blasi F. The urokinase plasminogen activator receptor as a target for cancer therapy. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 223-43. ISBN 978-0-387-69056-8.

RECEPTOR UROQUINASE; ATIVADOR DO PLASMINOGENIO; TERAPIA DO CANCER; SISTEMA UPA/UPAR; TRANSDUCAO DE SINAL; MOTILIDADE CELULAR; PROLIFERACAO CELULAR; CANCER; ESTRATEGIAS TERAPEUTICAS ANTISENSE; APOPTOSE


23654/34351US=65 / Biol/Mol
Hillig T, Engelholm LH, Behrendt N. The endocytic collagen receptor, uPARAP/Endol180, in cancer invasion and tissue remodeling. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 245-58. ISBN 978-0-387-69056-8.

RECEPTOR DO COLAGENO ENDOCITICA; UPARAP/ENDOL180; CANCER; REMODELACAO DO TECIDO


23655/34351US=65 / Biol/Mol
List K, Bugge TH. Physiological and pathological functions of type II transmembrane serine proteases: lessons from transgenic mouse models and human disease-associated mutations. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 259-79. ISBN 978-0-387-69056-8.

SERINAPROTEASES TRANSMEMBRANA TIPO II; FUNCOES FISIOLOGICAS E PATOLOGICAS; CAMUNDONGOS TRANSGENICOS; HUMANOS; MUTACOES; CANCER; FAMILIA TTSP


Primeira | Anterior | Próxima | Última